Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin
U. Keilholz, P. Martus, C. J.A. Punt, W. Kruit, G. Mooser, D. Schadendorf, D. Liénard, R. Dummer, J. Koller, C. Voit, A. M.M. Eggermont
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
50Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin'. Samen vormen ze een unieke vingerafdruk.